Third Hantavirus Death Linked to Yosemite Park, As Warning Expanded

A third person has reportedly died from a hantavirus infection linked to an outbreak among visitors to Yosemite Park, as federal health officials have expanded warnings to include another 12,000 visitors who stayed at the park over the summer.

Yosemite National Park indicates that individuals who were in the High Sierra Camps may have been exposed to the virus, which kills one out of every three people it infects. This warning is in addition to the 10,000 visitors alerted last week about the risk of hantavirus among those who stayed at Yosemite’s Curry Village “signature” tent cabins.

The additional warnings came after officials confirmed a third hantavirus death among a Yosemite park visitor, who passed away on Thursday. At least 8 people overall have been confirmed as having hantavirus after visiting Yosemite. Their identities have not been released.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

On September 4, the World Health Organization stepped in and issued a global alert for Hantavirus pulmonary syndrome (HPS) linked to the famous park.

“Travellers are advised to avoid exposure to rodents and their excreta,” the warning states. “Adventure travellers, backpackers, campers and travellers with occupational exposure to rodents in countries or areas at risk for Hantaviruses should take precautions to exclude rodents from tents or other accommodation and to protect all food from contamination by rodents.”

Health officials believe the Yosemite Park hantavirus outbreak was started by deer mice, who were able to invest the double-walled Signature tent cabins of Curry Village. A previous report estimated that about 20% of the deer mice in the park carry the Hantavirus.

Hantavirus is transferred to humans when they breathe air contaminated with the virus or come in contact with deer mouse saliva, urine or droppings infected with it. The deer mouse is native to the central and western United States and Canada.

The disease can incubate for up to six weeks until common symptoms, which are often confused with influenza, appear. Early symptoms include fever, headaches, muscle aches, stomach problems, dizziness and chills. Symptoms typically develop between one and five weeks after exposure and later symptoms of the virus also include coughing and shortness of breath.

Hantavirus has a mortality rate of 38 percent. A blood test can diagnose the virus and while there is no official treatment, it is commonly combated by placing a patient in intensive care and offering oxygen therapy.

Photo Courtesy of MiguelVieira via Flickr/CC 2.0

Image Credit: |


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted today)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 2 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.